Publications by authors named "Torsten Ginter"

Claim this Profile
S
STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling.
Anja Göder, Torsten Ginter, Thorsten Heinzel, Svenja Stroh, Jörg Fahrer

Cytokine· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3.
Torsten Ginter, Jörg Fahrer, Ulrike Kröhnert, Verena Fetz, Alessio Garrone

Cell Signal· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.
Sylvia Müller, Yuan Chen, Torsten Ginter, Claudia Schäfer, Marc Buchwald

Oncotarget· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.
Christian Kosan, Torsten Ginter, Thorsten Heinzel, Oliver H Krämer

JAKSTAT· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetylation of endogenous STAT proteins.
Torsten Ginter, Thorsten Heinzel, Oliver H Krämer

Methods Mol Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon alpha-armed nanoparticles trigger rapid and sustained STAT1-dependent anti-viral cellular responses.
Sibyll Pollok, Torsten Ginter, Katharina Günzel, Jana Pieper, Andreas Henke

Cell Signal· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetylation modulates the STAT signaling code.
Martin Wieczorek, Torsten Ginter, Peter Brand, Thorsten Heinzel, Oliver H Krämer

Cytokine Growth Factor Rev· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation.
Torsten Ginter, Carolin Bier, Shirley K Knauer, Kalsoom Sughra, Dagmar Hildebrand

Cell Signal· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
Roland H Stauber, Shirley K Knauer, Negusse Habtemichael, Carolin Bier, Britta Unruhe, Torsten Ginter

Oncotarget· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis